A new paradigm for clinical biomarker discovery and screening with Mass Spectrometry through biomedical image analysis principles. - Hanqing Liao; Emmanouil Moschidis; Isabel Riba-Garcia; Yan Zhang; Richard D. Unwin; Jeffrey S. Morris; Jim Graham; Andrew W. Dowsey (ISBI, 2014)

The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination. - Kathryn A. McGurk; Arianna Dagliati; Davide Chiasserini; Dave Lee; Darren Plant; Ivona Baricevic-Jones; Janet Kelsall; Rachael Eineman; Rachel Reed; Bethany Geary; Richard D. Unwin; Anna Nicolaou; et al. (Bioinform., 2020)